LUPIN LIMITED (LUPIN) financials

LUPIN LIMITED (LUPIN) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai. Lupin develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.

  • Market Cap: ₹88,486Cr.
  • Current Price: ₹1,935
  • Stock P/E: 13.4
  • ROE: 21.2%
  • ROCE: 26.2%
  • Book Value: ₹659
  • Dividend Yield: 0.93%
  • 52W High / Low: ₹2,530/1,900

In Jun 2026, LUPIN LIMITED (LUPIN) reported sales ₹7,172 Cr and net profit ₹2,715 Cr.

Annual TTM: sales ₹20,976 Cr, net profit ₹6,953 Cr.

Shareholding: Promoters 46.85% (Jun 2026), FIIs 22.42% (Jun 2026), DIIs 24.65% (Jun 2026), Government 0.00% (Jun 2026), Public 6.08% (Jun 2026).

LUPIN quarterly results (₹ Cr.)
CategorySep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales4,1064,2084,4865,7094,0684,5015,2357,172
Expenses2,9912,7972,7402,9792,8932,8852,9533,439
Operating Profit1,1151,4111,7462,7301,1761,6172,2823,733
OPM %27%34%39%48%29%36%44%52%
Other Income33-224954663-534537102
Interest1820341928363936
Depreciation146153208177175179177190
Profit before tax9841,2171,5532,5881,6368682,6023,610
Tax %18%19%17%18%17%17%17%25%
Net Profit8089851,2912,1281,3577172,1642,715
EPS in Rs17.7121.5828.2846.6029.7215.7147.3359.37
Raw PDF————————
LUPIN profit and loss (₹ Cr.)
CategoryMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales11,02611,05611,77211,25914,66616,96819,51320,976
Expenses9,1169,01211,56010,29511,21611,57412,33612,169
Operating Profit1,9092,0442119643,4515,3947,1768,807
OPM %17%18%1.8%9%24%32%37%42%
Other Income-2861292152101151761,346768
Interest534173985684121138
Depreciation519503514548725648707720
Profit before tax1,0521,630-1625272,7854,8377,6948,716
Tax %31%23%17%19%16%18%17%—
Net Profit7281,259-1894252,3263,9736,3676,953
EPS in Rs16.0627.74-4.159.3551.0587.02139.26152.13
Dividend Payout %37%23%-96%43%16%14%13%—
LUPIN balance sheet (₹ Cr.)
CategoryMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital9091919191919191
Reserves17,02717,38318,47518,05918,32120,51224,18730,042
Borrowings664859517491052501,115
Other Liabilities2,5673,2012,8083,2123,5234,2153,9044,854
Total Liabilities19,69020,68021,85922,31322,68424,92328,43236,103
Fixed Assets3,3733,5143,6393,6904,0224,1134,9464,873
CWIP1,199822951947927446278523
Investments7,3887,4569,5639,5119,97411,58111,95515,625
Other Assets7,7308,8887,7068,1657,7618,78311,25315,082
Total Assets19,69020,68021,85922,31322,68424,92328,43236,103
LUPIN cash flows (₹ Cr.)
CategoryMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity3,1112,2191,5701511,7942,5042,4455,540
Cash from Investing Activity-2,865-740-2,508-372-1,269-1,599-1,766-5,649
Cash from Financing Activity-295-368-53102-498-867-460-121
Net Cash Flow-501,112-991-1182738218-230
Free Cash Flow2,1701,7031,052-4421,2331,8151,1605,083
CFO/OP137%136%98%1%199%77%60%93%
LUPIN shareholding pattern (%)
CategorySep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters46.96%46.94%46.91%46.90%46.89%46.89%46.85%46.85%
FIIs21.50%22.04%21.46%21.25%20.50%21.50%21.70%22.42%
DIIs25.10%24.73%25.41%25.55%26.56%25.58%25.32%24.65%
Government0.01%0.01%0.01%0.00%0.00%0.00%0.00%0.00%
Public6.44%6.27%6.21%6.28%6.06%6.04%6.13%6.08%
No. of Shareholders2,79,2802,81,9882,83,2102,86,6042,80,2562,88,9312,90,4113,00,283
LUPIN key ratios
CategoryMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days120120105848796122129
Inventory Days216216236260230216239251
Days Payable118136104110119148146189
Cash Conversion Cycle218199237234197163215191
Working Capital Days171154146124110116153135
ROCE %16%10%9%-1%3%14%22%26%
LUPINUpdated 13 Oct 2026, 5:45

Lupin Limited

Market Cap

₹88,486Cr.

Current Price

₹1,935

High / Low

₹2,530/1,900

Stock P/E

13.4

ROE21.2%
ROCE26.2%
Book Value₹659
Face Value₹2.00
Dividend Yield0.93%

About

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai. Lupin develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days94146113179120120105848796122129
Inventory Days211214232229216216236260230216239251
Days Payable126126161150118136104110119148146189
Cash Conversion Cycle179234184258218199237234197163215191
Working Capital Days115169127219171154146124110116153135
ROCE %40%36%30%11%16%10%9%-1%3%14%22%26%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of LUPIN LIMITED (LUPIN)?

The reported market capitalisation for LUPIN LIMITED (LUPIN) is ₹88,486Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of LUPIN?

The current price shown for LUPIN LIMITED (LUPIN) on Fincrux is ₹1,935 with a 52-week high/low of ₹2,530/1,900.

What is the P/E ratio of LUPIN LIMITED (LUPIN)?

The stock P/E for LUPIN LIMITED (LUPIN) is 13.4 on Fincrux, with ROE at 21.2% and ROCE at 26.2%.

What were LUPIN latest quarterly results?

For Jun 2026, LUPIN LIMITED (LUPIN) reported sales ₹7,172 Cr and net profit ₹2,715 Cr (figures in ₹ crore unless noted).

What are LUPIN annual sales and net profit?

For TTM, LUPIN LIMITED (LUPIN) shows sales of ₹20,976 Cr and net profit of ₹6,953 Cr on the Fincrux profit & loss statement.

Who owns LUPIN LIMITED (LUPIN)?

Latest shareholding for LUPIN LIMITED (LUPIN) on Fincrux: Promoters 46.85% (Jun 2026), FIIs 22.42% (Jun 2026), DIIs 24.65% (Jun 2026), Government 0.00% (Jun 2026), Public 6.08% (Jun 2026).

Where can I find LUPIN LIMITED (LUPIN) financials?

LUPIN LIMITED (LUPIN) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show LUPIN balance sheet and cash flow?

Yes. The LUPIN LIMITED (LUPIN) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 13 October 2026 at 5:45


Designed & Shipped by Harshit Bansal